Fobie
Epidemiologia
Fobie stanowią jedne z najczęstszych zaburzeń psychicznych, z miesięczną chorobowością w USA wynoszącą od 4,0% do 11,1%, przewyższającą częstość dużej depresji czy nadużywania alkoholu. Fobie specyficzne mają wskaźniki rozpowszechnienia w ciągu życia na poziomie 7,4% i 12-miesięczne na 5,5-9%, z wyższą częstością u kobiet (9,8% w ciągu życia, 7,7% w 12 miesięcy) niż u mężczyzn (4,9% i 3,3%). Fobia społeczna dotyka około 7% populacji USA rocznie, z ryzykiem wystąpienia w ciągu życia około 13%, a agorafobia ma 12-miesięczną chorobowość około 1,7%. Współwystępowanie fobii z innymi zaburzeniami psychicznymi jest wysokie, sięgając do 81%, a fobie specyficzne często poprzedzają inne zaburzenia. Występuje wyraźna przewaga kobiet, ze stosunkiem 2:1 dla fobii specyficznych i 2,5:1 dla fobii społecznej, a także różnice w rozpowszechnieniu w zależności od regionu geograficznego i statusu socjoekonomicznego.
- Epidemiologia fobii
- Chorobowość fobii specyficznych
- Chorobowość fobii społecznej
- Chorobowość agorafobii
- Różnice płciowe w epidemiologii fobii
- Epidemiologia fobii w różnych grupach wiekowych
- Współwystępowanie fobii z innymi zaburzeniami
- Czynniki kulturowe i różnice międzynarodowe
- Upośledzenie i leczenie
- Wnioski z badań epidemiologicznych
Epidemiologia fobii
Fobie są jednymi z najpowszechniejszych zaburzeń psychicznych w populacji ogólnej. Badania epidemiologiczne wskazują, że fobie są bardziej rozpowszechnione niż duża depresja czy nadużywanie alkoholu, z miesięczną chorobowością wahającą się od 4,0% do 11,1% w Stanach Zjednoczonych1. Fobie stanowią najczęstsze zaburzenie psychiatryczne, z częstością występowania 4,0-11,1% w populacji, i są częstsze u kobiet, młodszych grup wiekowych oraz osób o niskim statusie socjoekonomicznym1.
Chorobowość fobii specyficznych
Fobie specyficzne należą do najczęstszych zaburzeń lękowych zarówno u mężczyzn, jak i kobiet1. Badania prowadzone w 22 krajach o różnym poziomie dochodów wykazały, że wskaźniki rozpowszechnienia fobii specyficznych w ciągu całego życia i w okresie 12 miesięcy wynoszą odpowiednio 7,4% i 5,5%12. Dane te są wyższe u kobiet (9,8% i 7,7%) niż u mężczyzn (4,9% i 3,3%) oraz wyższe w krajach o wysokich i wyższych średnich dochodach niż w krajach o niskich/niższych średnich dochodach12.
W USA 12-miesięczne wskaźniki chorobowości dla fobii specyficznych szacuje się na 7-9% ogólnej populacji12. Szacuje się, że około 12,5% dorosłych w USA doświadcza fobii specyficznych w pewnym momencie swojego życia, a wskaźniki dla kobiet są około dwukrotnie wyższe niż dla mężczyzn1. Według danych z National Comorbidity Survey Replication (NCS-R), 9,1% dorosłych w USA cierpiało na fobię specyficzną w ciągu ostatniego roku, przy czym wskaźniki były wyższe u kobiet (12,2%) niż u mężczyzn (5,8%)1.
W Europie wskaźniki chorobowości fobii specyficznych są zbliżone do tych w USA (około 6%), ale są ogólnie niższe w krajach azjatyckich, afrykańskich i latynoamerykańskich (2-4%)1. Badanie przeprowadzone w Dreźnie wykazało, że częstość występowania fobii specyficznych w ciągu całego życia wynosi 12,8%, z podtypami wahającymi się od 0,2% (wymiotowanie, infekcje) do 5,0% (zwierzęta)12.
Chorobowość fobii społecznej
Fobia społeczna (zaburzenie lękowe społeczne) występuje z 12-miesięczną chorobowością około 7% w USA1. Badania epidemiologiczne w USA wskazują, że około 7% populacji cierpi na lęk społeczny w dowolnym momencie, a ryzyko wystąpienia tego zaburzenia w ciągu życia wynosi około 13%1. Wskaźniki fobii społecznej wśród populacji Ameryki Południowej są podobne do tych w USA, podczas gdy Korea, Chiny i Japonia wykazują wyjątkowo niskie wskaźniki, odpowiednio 0,6%, 0,2% i 0,8%1.
Przegląd badań epidemiologicznych wykazał, że częstość występowania fobii społecznej u dorosłych w ciągu życia wahała się między 2% a 5%, ze stosunkiem kobiet do mężczyzn wynoszącym 2,5:11. Badania we Francji wykazały częstość występowania w ciągu całego życia na poziomie 2,1% u mężczyzn i 5,4% u kobiet1.
Chorobowość agorafobii
12-miesięczny wskaźnik chorobowości dla agorafobii w USA wynosi około 1,7%12. Częstość występowania agorafobii bez zaburzenia panicznego wynosi około 0,8%1. Wskaźnik współchorobowości agorafobii z innymi zaburzeniami lękowymi waha się od 49% do 60%, a z zaburzeniami depresyjnymi wynosi od 33,1% do 52%1.
Różnice płciowe w epidemiologii fobii
Zaburzenia fobiczne wykazują wyższą częstość występowania wśród kobiet. Badania wskazują na stosunek kobiet do mężczyzn wynoszący około 2:1 dla fobii specyficznych12. Ten stosunek może się jednak różnić w zależności od różnych bodźców fobicznych – fobie związane ze zwierzętami, środowiskiem naturalnym i sytuacyjne są częściej diagnozowane u kobiet, podczas gdy fobia krwi-zastrzyków-urazów jest diagnozowana równie często u obu płci1.
Szwedzkie badanie wykazało, że kobiety mają wyższą liczbę przypadków fobii rocznie niż mężczyźni (26,5% dla kobiet i 12,4% dla mężczyzn). Wśród dorosłych 21,2% kobiet i 10,9% mężczyzn ma pojedynczą fobię specyficzną, podczas gdy wielokrotne fobie występują u 5,4% kobiet i 1,5% mężczyzn1. Kobiety są prawie czterokrotnie bardziej narażone na strach przed zwierzętami (12,1% u kobiet i 3,3% u mężczyzn)1.
Agorafobia ma stosunek kobiet do mężczyzn wynoszący 2-3:11. Fobie społeczne są częstsze u dziewcząt niż u chłopców, podczas gdy fobia sytuacyjna występuje u 17,4% kobiet i 8,5% mężczyzn1.
Epidemiologia fobii w różnych grupach wiekowych
Fobie u dzieci i młodzieży
Poważne lęki występują u około 10-15% dzieci, a fobie specyficzne stwierdza się u około 5% dzieci1. U wielu dzieci te lęki i fobie zakłócają ich uczestnictwo i przyjemność z różnych zajęć, a także mogą wpływać na ich edukację, życie rodzinne lub życie społeczne1.
Według danych z National Comorbidity Survey Adolescent Supplement (NCS-A), częstość występowania fobii specyficznych w ciągu całego życia wśród amerykańskich nastolatków w wieku 13-18 lat wynosi 19,3%, a około 0,6% cierpi na poważne upośledzenie1. Częstość występowania fobii specyficznych wśród nastolatków była wyższa u dziewcząt (22,1%) niż u chłopców (16,7%)1.
Badanie meksykańskich nastolatków wykazało, że większość z nich zgłaszała co najmniej jeden lęk (76,5%), 36,5% z tych osób spełniało kryteria fobii specyficznej w ciągu całego życia, a 27,3% spełniało kryteria w ciągu ostatnich 12 miesięcy1. Wśród nastolatków z fobią specyficzną 71,3% rozpoznało swój lęk jako nadmierny, 9,7% do 12,3% zgłosiło poważne upośledzenie, a tylko 6,5% otrzymało leczenie1.
Fobie u osób dorosłych
Większość fobii specyficznych zaczyna się w dzieciństwie i ostatecznie zanika. Szacowana częstość występowania fobii specyficznych wynosi około 5% u młodszych dzieci i 16% u dzieci w wieku 13-17 lat. Częstość występowania jest niższa (3-5%) u starszych osób, prawdopodobnie odzwierciedlając spadek nasilenia do poziomów subklinicznych1.
W USA fobia społeczna ma tendencję do rozpoczynania się wcześnie w życiu, przy czym 75% pacjentów doświadcza jej początku między 8. a 15. rokiem życia, a mediana wieku w momencie wystąpienia wynosi 13 lat1. Częstość występowania zmniejsza się wraz z wiekiem; 12-miesięczna chorobowość dla osób starszych wynosi około 7%1.
Fobie u osób starszych
Częstość występowania zaburzeń lękowych w ciągu ostatniego roku wśród seniorów wahała się od 3,6% do 17,2%, przy czym najczęstszymi zaburzeniami są fobie specyficzne1. Badanie przeprowadzone w Madrycie wykazało, że 12,07% próby osób powyżej 65. roku życia cierpiało na zaburzenie fobii specyficznej w ciągu ostatniego roku1. Średni wiek wystąpienia fobii specyficznej wynosił 38,78 lat (odchylenie standardowe = 21,61)1.
Istnieje dodatkowy szczyt zapadalności, sięgający prawie 1% rocznie, w podeszłym wieku zarówno u mężczyzn, jak i kobiet, prawdopodobnie odzwierciedlający nowo pojawiające się stany fizyczne lub niekorzystne wydarzenia życiowe1.
Współwystępowanie fobii z innymi zaburzeniami
Wcześniejsze badania wykazały, że wskaźniki współwystępowania między fobią specyficzną a innymi zaburzeniami psychicznymi są wysokie, z szacowanymi wskaźnikami do 81,0%1. Współwystępowanie w ciągu całego życia zaobserwowano u 60,2% osób z fobią specyficzną w ciągu całego życia, przy czym w większości przypadków (72,6%) początek fobii specyficznej poprzedzał inne zaburzenie12.
Między podtypami fobii specyficznych pojawiły się również znaczące różnice we wzorcach współwystępowania1. U osób z fobią specyficzną często współwystępują inne zaburzenia lękowe, zaburzenia depresyjne i dwubiegunowe, zaburzenia związane z substancjami, zaburzenia somatyczne i zaburzenia osobowości (szczególnie zaburzenie osobowości zależnej)12.
W przypadku fobii społecznej współwystępowanie z innymi zaburzeniami lękowymi i dużą depresją było wysokie1. U nastolatków z fobią społeczną uogólnioną występowało znaczące współwystępowanie z zaburzeniem opozycyjno-buntowniczym (12,5% w porównaniu z nastolatkami z nieuogólnioną fobią społeczną)1.
Czynniki kulturowe i różnice międzynarodowe
Częstość występowania fobii społecznej w Stanach Zjednoczonych jest wyższa wśród rdzennych Amerykanów i niższa wśród osób pochodzenia azjatyckiego, latynoskiego, afroamerykańskiego i afrokaraibskiego w porównaniu z osobami rasy białej nie-latynoskiej1. Wskaźniki fobii specyficznej i agorafobii nie wydają się znacząco różnić między grupami kulturowymi lub rasowymi1.
Badanie przeprowadzone w Andaluzji wykazało, że częstość występowania zaburzenia lęku społecznego (SAD) wynosi 1,1% (95% CI=0,8-1,4), co jest podobne do poziomów zgłaszanych w innych międzynarodowych badaniach1.
Upośledzenie i leczenie
Fobie specyficzne są powszechne i związane z upośledzeniem w znacznym odsetku przypadków12. Wśród dorosłych z fobią specyficzną w ciągu ostatniego roku, stopień upośledzenia wahał się od łagodnego do poważnego. Szacunkowo 21,9% miało poważne upośledzenie, 30,0% miało umiarkowane upośledzenie, a 48,1% miało łagodne upośledzenie1.
Leczenie fobii specyficznej było trzykrotnie wyższe w krajach o wysokich dochodach niż w krajach o niskich i niższych średnich dochodach, co może wynikać z różnic w dostępności opieki i zasobów finansowych1. Mimo różnic w wskaźnikach leczenia, związki między poziomem upośledzenia a odsetkami zgłaszanego leczenia były porównywalne we wszystkich grupach dochodowych, przy czym osoby o ciężkim upośledzeniu zgłaszały najwięcej leczenia1.
Długoterminowa farmakoterapia fobii specyficznych wiąże się z niepożądanymi reakcjami na leki i nadużywaniem leków, dlatego nie jest rozsądnym wyborem do długoterminowej kontroli objawów1. Najszerzej badaną i najbardziej skuteczną psychoterapią w leczeniu fobii specyficznej jest terapia ekspozycyjna, której celem jest odwrócenie cyklu lęku i unikania1.
Wnioski z badań epidemiologicznych
Fobie specyficzne są powszechne i często poprzedzają wystąpienie innych zaburzeń psychicznych, co czyni je możliwym wczesnym wskaźnikiem podatności na psychopatologię123. Dane te sugerują znaczące różnice w fenomenologii i znaczeniu klinicznym podtypów fobii specyficznej1.
Duży odsetek nastolatków spełniających kryteria diagnostyczne w połączeniu z niewielkim odsetkiem osób z poważnym upośledzeniem sugeruje, że obecne progi diagnostyczne mogą być zbyt niskie lub niewrażliwe na rozwój1. Wczesne wykrycie i terminowe leczenie są ważne, biorąc pod uwagę, że fobia specyficzna jest trwała i wysoce współwystępująca, a niewiele osób szuka leczenia1.
Wyniki badań pokazują, że, wraz z wiekiem i płcią, wsparcie społeczne powinno być uważane za czynnik ochronny przed fobiami1. Występowanie zaburzenia fobii specyficznej obniżało poziom funkcjonowania i negatywnie wpływało na jakość życia osób powyżej 65. roku życia1.
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1https://consensus.app/questions/common-phobias/
Phobias are among the most common psychiatric disorders in the general population. Epidemiological studies indicate that phobias are more prevalent than major depression or alcohol abuse, with a one-month prevalence ranging from 4.0% to 11.1% in the United States. […] Phobias are the most common psychiatric disorder, with a prevalence rate of 4.0-11.1% in the community, and are more common in women, younger age groups, and those with low socioeconomic status. […] Common fears and phobias are prevalent in the general population, with mild phobias occurring 76:9/1000 and severe phobias 2.2/1000, with agoraphobia over-represented in clinical samples. […] Specific phobias have a lifetime prevalence of 3% to 15%, with heights and animals being the most common, and early treatment could reduce their prevalence and predict other mental disorders. […] Social phobia is a common and debilitating condition that impairs education and productivity, and accurate diagnosis and treatment are crucial for its proper management.
- #1https://www.ijbcp.com/index.php/ijbcp/article/view/305
Specific phobias are among the most common psychological problems both in men and women. […] Long-term pharmacotherapy for specific phobias, is associated with adverse drug reactions and drug abuse, thus not a reasonable choice for long-term symptom control. […] Kessler RC, Chiu WT, Demler O. Prevalence, severity and co-morbidity of 12 month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005;62:617-27. […] Fredrikson M, Annas P, Fischer H. Gender and age differences in the prevalence of specific fears and phobias. Behaviour research and therapy. 1996;34:33-9. […] Kendler KS, Neale MC, Kessler RC. The genetic epidemiology of phobias in women: the interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia. Arch General Psych. 1992;49:273-81.
- #1 The cross-national epidemiology of specific phobia in the World Mental Health Surveyshttps://pmc.ncbi.nlm.nih.gov/articles/PMC5674525/
Although specific phobia is highly prevalent, associated with impairment, and an important risk factor for the development of other mental disorders, cross-national epidemiological data are scarce, especially from low and middle-income countries. This paper presents epidemiological data from 22 low, lower-middle, upper-middle and high-income countries. […] The cross-national lifetime and 12-month prevalence rates of specific phobia were, respectively, 7.4% and 5.5%, being higher in females (9.8% and 7.7%) than in males (4.9% and 3.3%) and higher in high and higher-middle income countries than in low/lower-middle income countries. […] Specific phobia is common and associated with impairment in a considerable percentage of cases. Importantly, specific phobia often precedes the onset of other mental disorders, making it a possible early-life indicator of psychopathology vulnerability.
- #1 Phobia epidemiology and demographics – wikidochttps://www.wikidoc.org/index.php/Phobia_epidemiology_and_demographics
The 12 month prevalence of specific phobia is 7,000-9,000 per 100,000 (7%-9%) of the overall population. […] An American study by the National Institute of Mental Health (NIMH) found that between 8.7% and 18.1% of Americans suffer from phobias. […] Broken down by age and gender, the study found that phobias were the most common mental illness among women in all age groups and the second most common illness among men older than 25. […] Severe fears are present in about 10-15% of children and specific phobias are found in about 5% of children. […] For many children, these fears and phobias interfere with their participation in and enjoyment of various activities. It may also interfere with their education, family life, or their social life. However, effective treatment is available for children who experience phobias.
- #1 Specific phobia – Wikipediahttps://en.wikipedia.org/wiki/Specific_phobia
In the US, the lifetime prevalence rate is 12.5% and a one-year prevalence rate of 9.1%. […] An estimated 12.5% of U.S. adults experience specific phobia at some time in their lives and the prevalence is approximately double in females compared to males. […] An estimated 19.3% of adolescents experience specific phobia, but the difference between males and females is not as pronounced.
- #1 Specific Phobia – National Institute of Mental Health (NIMH)https://www.nimh.nih.gov/health/statistics/specific-phobia
Based on diagnostic interview data from National Comorbidity Survey Replication (NCS-R), Figure 1 shows past year prevalence of specific phobia among U.S. adults aged 18 or older. An estimated 9.1% of U.S. adults had specific phobia in the past year. Past year prevalence of specific phobia among adults was higher for females (12.2%) than for males (5.8%). An estimated 12.5% of U.S. adults experience specific phobia at some time in their lives. […] Of adults with specific phobia in the past year, degree of impairment ranged from mild to serious, as shown in Figure 2. Of adults with specific phobia in the past year, an estimated 21.9% had serious impairment, 30.0% had moderate impairment, and 48.1% had mild impairment. […] Based on diagnostic interview data from National Comorbidity Survey Adolescent Supplement (NCS-A), Figure 3 shows lifetime prevalence of specific phobia among U.S. adolescents aged 13-18. An estimated 19.3% of adolescents had specific phobia, and an estimated 0.6% had severe impairment. The prevalence of specific phobia among adolescents was higher for females (22.1%) than for males (16.7%).
- #1 Phobic Disorders: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/288016-overview
The 12-month prevalence rates for the United States are estimated as follows: Social anxiety disorder (social phobia) – 7%; Specific phobia – 7-9%; Agoraphobia – 1.7%. […] Social anxiety disorder appears to be less common in much of the world than it is in the United States, with 12-month prevalence estimates clustering in the range of 0.5-2.0%; median prevalence in Europe is 2.3%. Prevalence estimates for specific phobia in European countries are close to those in the United States (~6%) but are generally lower in Asian, African, and Latin American countries (2-4%). […] In the United States, social anxiety disorder tends to start early in life, with 75% of the patients experiencing its onset between ages 8 and 15 years and a median age at onset of 13 years. The 12-month prevalence estimates for social anxiety disorder in children and adolescents are comparable to those in adults. Prevalence decreases with advancing age; the 12-month prevalence for older adults is in approximately 7%.
- #1 Epidemiology of specific phobia subtypes: Findings from the Dresden Mental Health Study | European Psychiatry | Cambridge Corehttps://www.cambridge.org/core/journals/european-psychiatry/article/epidemiology-of-specific-phobia-subtypes-findings-from-the-dresden-mental-health-study/B6C1FD0DB451EDA2CD216BD4BA91A5F6
This study determined the prevalence, age of onset, comorbidity, and impairment associated with specific phobia subtypes in the community. […] The lifetime prevalence of any specific phobia was 12.8%, with subtypes ranging in prevalence between 0.2% (vomiting, infections) and 5.0% (animals). […] Significant differences in comorbidity patterns also emerged between subtypes. […] The findings suggest that specific phobias are common among young women and that they differ in prevalence, associated comorbidity, and mean age of onset. […] These data suggest significant differences in the phenomenology and clinical significance of specific phobia subtypes.
- #1 Azthena logo with the word Azthenahttps://www.news-medical.net/health/Social-Anxiety-Epidemiology.aspx
Social anxiety disorder (SAD) or social phobia is common in the general population, with a lifetime prevalence of 25% in adults. It presents as a fear of any situations in which interactions with other people are required. SAD is said to be the third most prevalent psychiatric disorder in the world. […] Epidemiological studies in the USA report that about 7% of the population is affected by social anxiety at any time, and the lifetime risk of the disorder is around 13%. SAD rates among the South American populations are similar to those of the USA, whereas Korea, China, and Japan show extremely low rates of 0.6%, 0.2%, and 0.8% respectively. Generally, high rates of SAD are found in Russia. […] A survey carried out in 2001-2002 in the USA showed that the following categories of people were more likely to have SAD: youth, people from a low-income group, native Americans, while the following were at less risk for SAD: males, Asians, Hispanics, and blacks, those living in urban areas.
- #1 Social phobia: epidemiology, recognition, and treatment | The BMJhttps://www.bmj.com/content/315/7111/796
Social phobia is common in the general population. A review of epidemiological studies found that the lifetime prevalence of social phobia in adults varied between 2% and 5% with a female:male ratio of 2.5:1. Patients may not consult their family doctor until they have had the condition for many years. The chronic course increases the risk of comorbid conditions, which may mask the social phobia. In children and adolescents the prevalence of social phobia is 0.9%-1.1%. The lifetime prevalence of simple phobia and social phobia in young adults (mean age 18 years) was found to be 23%;
- #1https://link.springer.com/article/10.1007/BF02190406
The individualization of social phobia among other phobic disorders is very recent, although previous clinical descriptions can be found in the literature. […] The new classifications (DSM-III, DSM-IV and ICD-10) have provided operationalized criteria for this disorder, which have allowed researchers to conduct epidemiological studies. […] Cross-cultural prevalence and risk factors of social phobia are reviewed. Results of a French community study have found a lifetime prevalence rate of 2.1% in males and 5.4% in females. […] Comorbidity of social phobia with other anxiety disorders and major depression was high. […] Suicidal tendencies, family history and health services utilization were analyzed according to the lifetime comorbidity pattern of social phobia and depression. […] The epidemiology of social phobia: findings from the Duke Epidemiologic Catchment Area Study. […] Comorbidity and social phobia: evidence from epidemiologic and genetic studies.
- #1 Azthena logo with the word Azthenahttps://www.news-medical.net/health/Agoraphobia-Epidemiology.aspx
Agoraphobia is usually defined as a part of panic disorder. The lifetime prevalence rate for agoraphobia with panic disorder is 1.1 percent. […] Agoraphobia has recently been redefined as a separate disorder that can occur with or without panic disorder. The prevalence of agoraphobia without panic disorder is about 0.8 percent. […] In another survey of adolescents and young adults, however, that did not follow the DSM-IV hierarchy rules requiring agoraphobia to be diagnosed within the context of panic disorder, the incidence of agoraphobia was 5.3 percent. When the DSM-IV rules were applied, that number dropped to 0.6 percent. […] The rate of comorbidity of agoraphobia with other anxiety disorders ranges from 49 to 60 percent, and with depressive disorders it is 33.1 to 52 percent. […] The median age of onset for agoraphobia is 20 years. Onset before the age of 55 is most common. The disorder typically does not remit without treatment. […] Heritability of agoraphobia is estimated at between 48 and 61 percent, meaning the genetic contribution is moderate with contributions from environmental factors being influential.
- #1 Phobic Disorders: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/288016-overview
Females are more frequently affected by specific phobia than males, at a rate of approximately 2:1, though rates vary across different phobic stimuli. […] Agoraphobia has a female-to-male ratio of 2-3:1. […] The prevalence of social anxiety disorder in the United States is higher in American Indians and lower in persons of Asian, Latino, African American, and Afro-Caribbean descent as compared with non-Hispanic white individuals. Prevalence figures for specific phobia and agoraphobia appear not to vary substantially across cultural or racial groups.
- #1 4.3: Specific Phobia – Social Sci LibreTextshttps://socialsci.libretexts.org/Bookshelves/Psychology/Psychological_Disorders/Essentials_of_Abnormal_Psychology_(Bridley_and_Daffin)/04%3A_Anxiety_Disorders/4.03%3A_Specific_Phobia
The prevalence rate for specific phobias is 7-9% within the united states. […] There is a 2:1 ratio of females to males diagnosed with specific phobia; however, this rate changes depending on the different phobic stimuli. […] More specifically, animal, natural environment, and situational specific phobias are more commonly diagnosed in females, whereas blood-injection-injury phobia is reportedly diagnosed equally between genders.
- #1 Phobia – Wikipediahttps://en.wikipedia.org/wiki/Phobia
Phobias are a common form of anxiety disorder, and distributions are heterogeneous by age and gender. An American study by the National Institute of Mental Health (NIMH) found that between 8.7 percent and 18.1 percent of Americans have phobias, making it the most common mental illness among women in all age groups and the second most common illness among men older than 25. Between 4 percent and 10 percent of all children experience specific phobias during their lives, and social phobias occur in one percent to three percent of children. […] A Swedish study found that females have a higher number of cases per year than males (26.5 percent for females and 12.4 percent for males). Among adults, 21.2 percent of women and 10.9 percent of men have a single specific phobia, while multiple phobias occur in 5.4 percent of females and 1.5 percent of males. Women are nearly four times as likely as men to have a fear of animals (12.1 percent in women and 3.3 percent in men) a higher dimorphic than with all specific or generalized phobias or social phobias. Social phobias are more common in girls than boys, while situational phobia occurs in 17.4 percent of women and 8.5 percent of men.
- #1 Epidemiology of Fears and Specific Phobia in Adolescence: Results From the Mexican Adolescent Mental Health Surveyhttps://www.psychiatrist.com/jcp/epidemiology-fears-specific-phobia-adolescence-results/
Specific phobia is among the most common disorders in the general adolescent population, but also among the least studied. The objectives of this study were to estimate the prevalence of specific fears among adolescents, the proportion of those with fears who meet criteria for specific phobia, and the proportion who recognize their fears as excessive and to identify comorbidity with other disorders and factors associated with severity and treatment. […] Most adolescents reported at least 1 fear (76.5%); 36.5% of those met lifetime criteria for specific phobia, and 27.3% met criteria in the prior 12 months. […] Among teens with specific phobia, 71.3% recognized their fear as excessive, 9.7% to 12.3% reported severe impairment, and only 6.5% had received treatment. […] The large percentage of adolescents meeting diagnostic criteria coupled with the low proportion with serious impairment suggests that current diagnostic thresholds may be too low or not developmentally sensitive. Future research should address the nature of impairment for adolescents with specific phobia. Early detection and timely treatment are important given that specific phobia is persistent and highly comorbid and that few individuals seek treatment.
- #1 Phobic Disorders: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/288016-overview
In general, specific phobia appears earlier than either social anxiety disorder or agoraphobia does. Most such phobias develop during childhood and eventually disappear. The estimated prevalence of specific phobia is approximately 5% in younger children and 16% in children aged 13-17 years. The prevalence is lower (3-5%) in older individuals, possibly reflecting a decrease in severity to subclinical levels. […] The 12-month prevalence of agoraphobia in adolescents and adults is approximately 1.7%. Agoraphobia may occur in childhood, but the incidence peaks in late adolescence and early adulthood. The 12-month prevalence in individuals older than 65 years is 0.4%. […] The phobic disorders appear to have a higher incidence among women. Higher rates of social anxiety disorder are found in females in the general population (with female-to-male ratios ranging from 1.5:1 to 2.2:1), and the sex difference in prevalence is more pronounced in adolescents and young adults.
- #1 Prevalence and Characterization of Specific Phobia Disorder in People over 65 Years Old in a Madrid Community Sample (Spain) and its Relationship to Quality of Lifehttps://www.mdpi.com/1660-4601/17/6/1915
The prevalence of anxiety disorders over the last year among seniors ranged from 3.6% to 17.2%. The most prevalent disorders are specific phobias. […] A total of 12.07% of the sample suffered a specific phobia disorder over the last year. […] The average age at onset of the specific phobia was 38.78 (sd = 21.61) years. […] A significant effect of the specific phobia was found for the current levels of functioning and quality of life: WHOQOL-BREF total score (p < 0.05), WHODAS II overall score (p < 0.01), and HoNOS65+ total score (p < 0.001). [...] Having specific phobia disorder decreased the level of functioning and negatively affected the quality of life. [...] The results show a 12-month prevalence of specific phobia disorder of approximately 12% among people over 65 years old. [...] The current study revealed that, along with age and gender, social support should be considered as a protective factor against phobias among this age group. [...] Having specific phobia disorder decreased the level of functioning and negatively affected the quality of life of people over 65 years old.
- #1 Specific phobia – Wikipediahttps://en.wikipedia.org/wiki/Specific_phobia
Specific phobia is estimated to affect 6-12% of people at some point in their life. […] There may be a large amount of underreporting of specific phobias as many people do not seek treatment, with some surveys conducted in the US finding that 70% of the population reports having one or more unreasonable fears. […] Specific phobias have a lifetime prevalence rate of 7.4% and a one-year prevalence of 5.5% according to data collected from 22 different countries. […] The usual age of onset is childhood to adolescence. […] During childhood and adolescence, the incidence of new specific phobias is much higher in females than males. […] The peak incidence for specific phobias amongst females occurs during reproduction and childrearing, possibly reflecting an evolutionary advantage. […] There is an additional peak in incidence, reaching nearly 1% per year, during old age in both men and women, possibly reflective of newly occurring physical conditions or adverse life events.
- #1 The cross-national epidemiology of specific phobia in the World Mental Health Surveyshttps://pmc.ncbi.nlm.nih.gov/articles/PMC5674525/
Previous surveys have shown that comorbidity rates between specific phobia and other mental disorders are high, with estimated rates of up to 81.0%. […] Lifetime comorbidity was observed in 60.2% of those with lifetime specific phobia, with the onset of specific phobia preceding the other disorder in most cases (72.6%). […] Treatment for specific phobia was threefold higher in high-income countries than in low-lower middle income countries, which could be due to differences in the availability of care and financial resources. […] Despite differences in treatment rates, associations between the level of impairment and percentages of reported treatment were comparable across the income groups, with severely impaired cases reporting most treatment.
- #1 Specific Phobias – Psychiatric Disorders – Merck Manual Professional Editionhttps://www.merckmanuals.com/professional/psychiatric-disorders/anxiety-and-stressor-related-disorders/specific-phobias
Specific phobias are the most common anxiety disorders. Specific phobias affect approximately 8% of women and 3% of men during any 12-month period (1). The diagnosis of a specific phobia should not be made if the clinical situation is better described by another diagnosis. Of note, a specific phobia is commonly comorbid with a variety of other psychiatric conditions, including other anxiety disorders, depressive and bipolar disorders, substance-related disorders, somatic symptom and related disorders, and personality disorders (particularly dependent personality disorder). […] The prognosis for untreated specific phobias varies because certain uncommon situations or objects (eg, snakes, caves) are easy to avoid, whereas other situations or objects (eg, bridges, thunderstorms) are common and difficult to avoid. […] The most extensively studied and most effective psychotherapy for specific phobia is exposure therapy, which aims to reverse the cycle of anxiety and avoidance (1).
- #1 Social Phobia: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/290854-overview
A smaller percentage (3.8%) of all adolescents, representing 44.2% of all those adolescents with social phobia, had nongeneralized type of social phobiafewer than 7 types of fears. […] A very much smaller percentage of all adolescents (0.7%) had performance social phobia, representing only 0.8% of all adolescents with social phobia. […] Disability from social phobia of the generalized type was moderate to severe and highly persistent; 87.03% of adolescents experienced at least 7 fears for 4 days of the previous calendar year, and there was a high comorbidity with social phobia. […] The lifetime incidence of comorbid oppositional defiant disorder occurred in a significant number of adolescents, more so in those with generalized social phobia (12.5% compared with adolescents who had the nongeneralized type of social phobia). […] The lifetime prevalence of social phobia is estimated at 7%-12%. […] Social phobia often goes undiagnosed in patients with other coexisting acute psychiatric conditions such as depression or suicidality but should not be overlooked, as it can contribute to a lack of symptom remission.
- #1 Epidemiology of social phobia in Andalusia | Spanish Journal of Psychiatry and Mental Healthhttps://www.elsevier.es/es-revista-spanish-journal-psychiatry-mental-health-250-articulo-epidemiology-social-phobia-in-andalusia-S188898912100118X
Epidemiology of social phobia in Andalusia […] Population studies on social anxiety disorder (SAD) are relatively scarce and there is no previous reported evidence on prevalence or correlates of SAD in an Andalusian general population sample. […] Estimated prevalence for SAD was 1.1% (95% CI=0.8-1.4). […] Among this large Andalusian population sample, the prevalence of SAD and its associated factors are relatively similar to previously reported international studies, although no population study had previously reported such a strong association with paranoia. […] The prevalence of SAD in Andalusia amounts to 1.1%, which is similar to the levels reported in other international studies.
- #2 The cross-national epidemiology of specific phobia in the World Mental Health Surveys | Psychological Medicine | Cambridge Corehttps://www.cambridge.org/core/journals/psychological-medicine/article/crossnational-epidemiology-of-specific-phobia-in-the-world-mental-health-surveys/A0EDD4B22E19CDB63269D7A34F2C21AA
Although specific phobia is highly prevalent, associated with impairment, and an important risk factor for the development of other mental disorders, cross-national epidemiological data are scarce, especially from low- and middle-income countries. This paper presents epidemiological data from 22 low-, lower-middle-, upper-middle- and high-income countries. […] The cross-national lifetime and 12-month prevalence rates of specific phobia were, respectively, 7.4% and 5.5%, being higher in females (9.8 and 7.7%) than in males (4.9% and 3.3%) and higher in high- and higher-middle-income countries than in low-/lower-middle-income countries. […] Specific phobia is common and associated with impairment in a considerable percentage of cases. Importantly, specific phobia often precedes the onset of other mental disorders, making it a possible early-life indicator of psychopathology vulnerability.
- #2 Phobic Disorders: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/288016-overview
The 12-month prevalence rates for the United States are estimated as follows: Social anxiety disorder (social phobia) – 7%; Specific phobia – 7-9%; Agoraphobia – 1.7%. […] Social anxiety disorder appears to be less common in much of the world than it is in the United States, with 12-month prevalence estimates clustering in the range of 0.5-2.0%; median prevalence in Europe is 2.3%. Prevalence estimates for specific phobia in European countries are close to those in the United States (~6%) but are generally lower in Asian, African, and Latin American countries (2-4%). […] In the United States, social anxiety disorder tends to start early in life, with 75% of the patients experiencing its onset between ages 8 and 15 years and a median age at onset of 13 years. The 12-month prevalence estimates for social anxiety disorder in children and adolescents are comparable to those in adults. Prevalence decreases with advancing age; the 12-month prevalence for older adults is in approximately 7%.
- #2 (PDF) Epidemiology of specific phobia subtypes: Findings from the Dresden Mental Health Studyhttps://www.academia.edu/18307154/Epidemiology_of_specific_phobia_subtypes_Findings_from_the_Dresden_Mental_Health_Study
This study determined the prevalence, age of onset, comorbidity, and impairment associated with specific phobia subtypes in the community. […] The lifetime prevalence of any specific phobia was 12.8%, with subtypes ranging in prevalence between 0.2% (vomiting, infections) and 5.0% (animals). […] Significant differences in comorbidity patterns also emerged between subtypes. […] The findings suggest that specific phobias are common among young women and that they differ in prevalence, associated comorbidity, and mean age of onset. […] Specific phobia is the most prevalent anxiety disorder in the community and is associated with substantial impairment. […] Specific phobias are heterogeneous with respect to sociodemographic characteristics and comorbidity pattern. […] The overall prevalence of phobia in children and adolescents was 19.7%.
- #2 Phobic Disorders: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/288016-overview
In general, specific phobia appears earlier than either social anxiety disorder or agoraphobia does. Most such phobias develop during childhood and eventually disappear. The estimated prevalence of specific phobia is approximately 5% in younger children and 16% in children aged 13-17 years. The prevalence is lower (3-5%) in older individuals, possibly reflecting a decrease in severity to subclinical levels. […] The 12-month prevalence of agoraphobia in adolescents and adults is approximately 1.7%. Agoraphobia may occur in childhood, but the incidence peaks in late adolescence and early adulthood. The 12-month prevalence in individuals older than 65 years is 0.4%. […] The phobic disorders appear to have a higher incidence among women. Higher rates of social anxiety disorder are found in females in the general population (with female-to-male ratios ranging from 1.5:1 to 2.2:1), and the sex difference in prevalence is more pronounced in adolescents and young adults.
- #2 4.3: Specific Phobia – Social Sci LibreTextshttps://socialsci.libretexts.org/Bookshelves/Psychology/Psychological_Disorders/Essentials_of_Abnormal_Psychology_(Bridley_and_Daffin)/04%3A_Anxiety_Disorders/4.03%3A_Specific_Phobia
The prevalence rate for specific phobias is 7-9% within the united states. […] There is a 2:1 ratio of females to males diagnosed with specific phobia; however, this rate changes depending on the different phobic stimuli. […] More specifically, animal, natural environment, and situational specific phobias are more commonly diagnosed in females, whereas blood-injection-injury phobia is reportedly diagnosed equally between genders.
- #2 The cross-national epidemiology of specific phobia in the World Mental Health Surveyshttps://lirias.kuleuven.be/807875?limo=0
BACKGROUND: Although specific phobia is highly prevalent, associated with impairment, and an important risk factor for the development of other mental disorders, cross-national epidemiological data are scarce, especially from low- and middle-income countries. […] The cross-national lifetime and 12-month prevalence rates of specific phobia were, respectively, 7.4% and 5.5%, being higher in females (9.8 and 7.7%) than in males (4.9% and 3.3%) and higher in high- and higher-middle-income countries than in low-/lower-middle-income countries. […] Lifetime co-morbidity was observed in 60.5% of those with lifetime specific phobia, with the onset of specific phobia preceding the other disorder in most cases (72.6%). […] Specific phobia is common and associated with impairment in a considerable percentage of cases. Importantly, specific phobia often precedes the onset of other mental disorders, making it a possible early-life indicator of psychopathology vulnerability.
- #2 4.3 Specific Phobia – Fundamentals of Psychological Disordershttps://opentext.wsu.edu/fundamentalsofpsychologicaldisorders/chapter/4-3-specific-phobia/
Specific phobia is distinguished by an individuals fear or anxiety specific to an object or a situation. […] The prevalence rate for specific phobias is 7-9% within the U.S. […] There is a 2:1 ratio of females to males diagnosed with specific phobia; however, this rate changes depending on the specific phobic stimuli. […] Rates of specific phobia are lower in Asian, African, and Latin American countries, with prevalence estimates around 2-4%. […] Given the onset of specific phobia occurs at a younger age than most other anxiety disorders, it is generally the primary diagnosis with generalized anxiety disorder as an occasional comorbid diagnosis. […] It should be noted that people with specific phobia are at an increased risk for other disorders including other anxiety disorders, depressive disorders, bipolar disorders, substance-related disorders, somatic symptom disorders, and dependent personality disorder.
- #3 The cross-national epidemiology of specific phobia in the World Mental Health Surveyshttps://lirias.kuleuven.be/807875?limo=0
BACKGROUND: Although specific phobia is highly prevalent, associated with impairment, and an important risk factor for the development of other mental disorders, cross-national epidemiological data are scarce, especially from low- and middle-income countries. […] The cross-national lifetime and 12-month prevalence rates of specific phobia were, respectively, 7.4% and 5.5%, being higher in females (9.8 and 7.7%) than in males (4.9% and 3.3%) and higher in high- and higher-middle-income countries than in low-/lower-middle-income countries. […] Lifetime co-morbidity was observed in 60.5% of those with lifetime specific phobia, with the onset of specific phobia preceding the other disorder in most cases (72.6%). […] Specific phobia is common and associated with impairment in a considerable percentage of cases. Importantly, specific phobia often precedes the onset of other mental disorders, making it a possible early-life indicator of psychopathology vulnerability.